Trials / Completed
CompletedNCT03886103
Pharmacokinetics and Metabolism of (14C)-Labelled PXL770
Pharmacokinetics and Metabolism of [14C]-Labelled PXL770 Following a Single Oral Administration in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Poxel SA · Industry
- Sex
- Male
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a single-dose, single center, single-period, open-label, non-randomized, mass balance recovery study in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 14C labeled PXL770 | Single administration |
Timeline
- Start date
- 2019-02-06
- Primary completion
- 2019-03-15
- Completion
- 2019-03-15
- First posted
- 2019-03-22
- Last updated
- 2019-03-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03886103. Inclusion in this directory is not an endorsement.